PFA herewith Investor Call Intimation
Awaiting price reaction for this filing.
Ajanta Pharma has informed the exchanges that it will release its Q4 FY2025 audited financial results on 30th April 2025, following a Board meeting. The same day, the company will host an earnings conference call at 4:30 PM IST, where the leadership team will discuss financial performance and take questions from analysts and investors. Dial-in access is available for participants in India, USA, UK, Hong Kong, and Singapore, with a Diamond Pass registration link for faster connectivity. A transcript and audio playback of the call will be made available on the company's website (www.ajantapharma.com) shortly after the call. The intimation has been filed with BSE and NSE under SEBI's Listing Regulations (Reg 30).
This is a standard pre-results announcement — investors should mark 30th April to track Q4 FY25 earnings and listen to management commentary, which often drives short-term stock movement. No new business or financial information is disclosed here.